prikaz prve stranice dokumenta An Additional Perspective on Proton Pump Inhibitors as Risk Factors for COVID-19
  Preuzmi
PDF 615.28 KB
Stručni rad - Ostalo
An Additional Perspective on Proton Pump Inhibitors as Risk Factors for COVID-19
Clinical Drug Investigation, 41 (2021), 3; 287-289. https://doi.org/10.1007/s40261-021-01007-8
Homolak, Jan; Kodvanj, Ivan; Trkulja, Vladimir

Povezani objekti
COVID-19 | Virtualna zbirka
Citirajte ovaj rad

Homolak, J., Kodvanj, I. i Trkulja, V. (2021). An Additional Perspective on Proton Pump Inhibitors as Risk Factors for COVID-19. Clinical Drug Investigation, 41. (3), 287-289. doi: 10.1007/s40261-021-01007-8

Homolak, Jan, et al. "An Additional Perspective on Proton Pump Inhibitors as Risk Factors for COVID-19." Clinical Drug Investigation, vol. 41, br. 3, 2021, str. 287-289. https://doi.org/10.1007/s40261-021-01007-8

Homolak, Jan, Ivan Kodvanj i Vladimir Trkulja. "An Additional Perspective on Proton Pump Inhibitors as Risk Factors for COVID-19." Clinical Drug Investigation 41, br. 3 (2021): 287-289. https://doi.org/10.1007/s40261-021-01007-8

Homolak, J., Kodvanj, I. i Trkulja, V. (2021) 'An Additional Perspective on Proton Pump Inhibitors as Risk Factors for COVID-19', Clinical Drug Investigation, 41(3), str. 287-289. doi: 10.1007/s40261-021-01007-8

Homolak J, Kodvanj I, Trkulja V. An Additional Perspective on Proton Pump Inhibitors as Risk Factors for COVID-19. Clinical Drug Investigation [Internet]. 03.2021. [pristupljeno 04.10.2024.];41(3):287-289. doi: 10.1007/s40261-021-01007-8

J. Homolak, I. Kodvanj i V. Trkulja, "An Additional Perspective on Proton Pump Inhibitors as Risk Factors for COVID-19", Clinical Drug Investigation, vol. 41, br. 3, str. 287-289, Ožujak 2021. [Online]. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:105:944205. [Citirano: 04.10.2024.]

Za citiranje koristite ovu mrežnu adresu: https://urn.nsk.hr/urn:nbn:hr:105:944205
Prijavite se u repozitorij kako biste mogli spremiti objekt u svoju listu.
Podaci o radu
Naslov (engleski)An Additional Perspective on Proton Pump Inhibitors as Risk Factors for COVID-19
AutorJan Homolak https://orcid.org/0000-0003-1508-3243
AutorIvan Kodvanj https://orcid.org/0000-0002-1359-3701
AutorVladimir Trkulja
Autorova ustanovaSveučilište u Zagrebu
Medicinski fakultet
(KATEDRA ZA TEMELJNU I KLINIČKU FARMAKOLOGIJU)
Znanstveno / umjetničko
područje, polje i grana		BIOMEDICINA I ZDRAVSTVO
Temeljne medicinske znanosti
Farmakologija
Ključne riječi (engleski)
Jezikengleski
Vrsta publikacijeStručni rad - Ostalo
Status objaveObjavljen
Vrsta recenzijeRecenziran
Verzija publikacijeObjavljena verzija rada (izdavačev PDF)
Naslov časopisaClinical Drug Investigation
Brojčani podacivol. 41, br. 3, str. 287-289
p-ISSN1173-2563
e-ISSN1179-1918
DOIhttps://doi.org/10.1007/s40261-021-01007-8
URN:NBNurn:nbn:hr:105:944205
Datum objave publikacije2021-03
URL dokumentahttp://link.springer.com/10.1007/s40261-021-01007-8
Vrsta resursaTekst
Prava pristupaOtvoreni pristup
Uvjeti korištenjaIkona licence Zaštićeno autorskim pravom.
Datum i vrijeme pohrane2021-06-29 08:12:38